Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Li-Yuan Bai

Showing results (81-90 of 154) with videos related to

Pageof 16
Sort By:
NPJ Precision Oncology|August 30, 2025
Circulating miRNAs as potentially predictive biomarkers for chemoimmunotherapy in advanced biliary tract cancer: a post-hoc analysis of the phase II T1219 studyNai-Jung Chiang, Cheng-Yu Tang, Li-Yuan Bai, et al.
British Journal of Haematology|April 8, 2011
OSU-DY7, a novel D-tyrosinol derivative, mediates cytotoxicity in chronic lymphocytic leukaemia and Burkitt lymphoma through p38 mitogen-activated protein kinase pathwayLi-Yuan Bai, Yihui Ma, Samuel K Kulp, et al.
International Journal of Hematology|February 28, 2022
Antithymocyte globulin plus post-transplant cyclophosphamide combination as graft-versus-host disease prophylaxis in haploidentical peripheral blood stem cell transplantation for hematological malignanciesTzu-Ting Chen, Ching-Chan Lin, Wen-Jyi Lo, et al.
Biomedicines|August 23, 2020
Ilimaquinone Induces Apoptosis and Autophagy in Human Oral Squamous Cell Carcinoma CellsCheng-Wen Lin, Li-Yuan Bai, Jui-Hsin Su, et al.
International Journal of Clinical Oncology|December 10, 2025
Intraperitoneal nivolumab for malignant ascites in patients with advanced gastrointestinal or pancreaticobiliary tract cancerHsiu-Tzu Wang, Yung-Luen Yu, Wen-Jyi Lo, et al.
Plos One|September 8, 2012
Kinetics of T helper subsets and associated cytokines correlate well with the clinical activity of graft-versus-host diseaseSu-Peng Yeh, Yu-Min Liao, Wen-Jyi Lo, et al.
Scientific Reports|January 8, 2022
Endoscopic ultrasound-guided fine-needle biopsy as a tool for studying the intra-tumoral microbiome in pancreatic ductal adenocarcinoma: a pilot studyChia-Sheng Chu, Chi-Ying Yang, Chun-Chieh Yeh, et al.
Oncoimmunology|October 1, 2021
Negative prognostic implications of splenomegaly in nivolumab-treated advanced or recurrent pancreatic adenocarcinomaShih-Hung Yang, Li-Chun Lu, Hsiang-Fong Kao, et al.
Cancers|March 28, 2024
Venetoclax Plus Azacitidine as a Bridge Treatment to Allogeneic Stem Cell Transplantation in Unfit Patients with Acute Myeloid LeukemiaTzu-Ting Chen, Ching-Chan Lin, Wen-Jyi Lo, et al.
Cancer Chemotherapy and Pharmacology|February 18, 2014
A multicenter phase II study of biweekly capecitabine in combination with oxaliplatin as first-line chemotherapy in patients with locally advanced or metastatic gastric cancerYee Chao, Jan-Sing Hsieh, Hsien-Tang Yeh, et al.
Pageof 16

Showing results (81-90 of 154) with videos related to

Sort By:
Pageof 16
NPJ Precision Oncology|August 30, 2025
Circulating miRNAs as potentially predictive biomarkers for chemoimmunotherapy in advanced biliary tract cancer: a post-hoc analysis of the phase II T1219 studyNai-Jung Chiang, Cheng-Yu Tang, Li-Yuan Bai, et al.
British Journal of Haematology|April 8, 2011
OSU-DY7, a novel D-tyrosinol derivative, mediates cytotoxicity in chronic lymphocytic leukaemia and Burkitt lymphoma through p38 mitogen-activated protein kinase pathwayLi-Yuan Bai, Yihui Ma, Samuel K Kulp, et al.
International Journal of Hematology|February 28, 2022
Antithymocyte globulin plus post-transplant cyclophosphamide combination as graft-versus-host disease prophylaxis in haploidentical peripheral blood stem cell transplantation for hematological malignanciesTzu-Ting Chen, Ching-Chan Lin, Wen-Jyi Lo, et al.
Biomedicines|August 23, 2020
Ilimaquinone Induces Apoptosis and Autophagy in Human Oral Squamous Cell Carcinoma CellsCheng-Wen Lin, Li-Yuan Bai, Jui-Hsin Su, et al.
International Journal of Clinical Oncology|December 10, 2025
Intraperitoneal nivolumab for malignant ascites in patients with advanced gastrointestinal or pancreaticobiliary tract cancerHsiu-Tzu Wang, Yung-Luen Yu, Wen-Jyi Lo, et al.
Plos One|September 8, 2012
Kinetics of T helper subsets and associated cytokines correlate well with the clinical activity of graft-versus-host diseaseSu-Peng Yeh, Yu-Min Liao, Wen-Jyi Lo, et al.
Scientific Reports|January 8, 2022
Endoscopic ultrasound-guided fine-needle biopsy as a tool for studying the intra-tumoral microbiome in pancreatic ductal adenocarcinoma: a pilot studyChia-Sheng Chu, Chi-Ying Yang, Chun-Chieh Yeh, et al.
Oncoimmunology|October 1, 2021
Negative prognostic implications of splenomegaly in nivolumab-treated advanced or recurrent pancreatic adenocarcinomaShih-Hung Yang, Li-Chun Lu, Hsiang-Fong Kao, et al.
Cancers|March 28, 2024
Venetoclax Plus Azacitidine as a Bridge Treatment to Allogeneic Stem Cell Transplantation in Unfit Patients with Acute Myeloid LeukemiaTzu-Ting Chen, Ching-Chan Lin, Wen-Jyi Lo, et al.
Cancer Chemotherapy and Pharmacology|February 18, 2014
A multicenter phase II study of biweekly capecitabine in combination with oxaliplatin as first-line chemotherapy in patients with locally advanced or metastatic gastric cancerYee Chao, Jan-Sing Hsieh, Hsien-Tang Yeh, et al.
Pageof 16